Retatrutide (LY-3437943) is an investigational drug developed by Eli Lilly that acts as a triple hormone receptor agonist : GLP-1 (glucagon-like peptide-1) receptor agonist GIP (glucose-dependent insulinotropic polypeptide) receptor agonist Glucagon receptor agonist - read about why this is so important here This triagonist approach amplifies the metabolic impact seen with GLP-1 and GIP combinations like tirzepatide, while also leveraging glucagons thermogenic and energy-expending properties
Read On Facial Slimming: How to Lose Face Fat & Refine Your Features Facial slimming is all the rage, and it's no surprise
doi: 10.1056/NEJMoa2306963 20 MarxNFedericiMSchttKMller-WielandDAjjanRAAntunesMJet al
Franck G, Mawson TL, Folco EJ, Molinaro R, Ruvkun V, Engelbertsen D, et al
While many doctors prescribe it this way, insurance companies may not cover it for this purpose
The best dose of Mounjaro for weight loss can be between 5 mg and 15 mg